Global Immune Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Immune Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Immune Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Immune Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Immune Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Immune Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Immune Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immune Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immune Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Antares Pharma, Inc., UCB, Incyte, GSK and Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Immune Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Immune Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immune Drugs, with price, sales, revenue and global market share of Immune Drugs from 2018 to 2023.
Chapter 3, the Immune Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immune Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Immune Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immune Drugs.
Chapter 14 and 15, to describe Immune Drugs sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Immune Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Immune Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Immune Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Immune Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Immune Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immune Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immune Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Antares Pharma, Inc., UCB, Incyte, GSK and Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Immune Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Immune Boosting Drugs
- Immunosuppressant Drugs
- Hospital
- Clinic
- Surgery Center
- Others
- Antares Pharma, Inc.
- UCB
- Incyte
- GSK
- Takeda
- 3S Bio
- Horizo??n Therapeutics
- Bristol-Myers Squibb (BMS
- Astellas
- Eli Lilly
- Mitsubishi Tanabe Pharma
- Biogen
- Pfizer
- Sanofi
- Roche
- Novartis
- Johnson & Johnson (J&J)
- Amgen
- Abbvi
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Immune Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immune Drugs, with price, sales, revenue and global market share of Immune Drugs from 2018 to 2023.
Chapter 3, the Immune Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immune Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Immune Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immune Drugs.
Chapter 14 and 15, to describe Immune Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Immune Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immune Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Immune Boosting Drugs
1.3.3 Immunosuppressant Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Immune Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Surgery Center
1.4.5 Others
1.5 Global Immune Drugs Market Size & Forecast
1.5.1 Global Immune Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Immune Drugs Sales Quantity (2018-2029)
1.5.3 Global Immune Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Antares Pharma, Inc.
2.1.1 Antares Pharma, Inc. Details
2.1.2 Antares Pharma, Inc. Major Business
2.1.3 Antares Pharma, Inc. Immune Drugs Product and Services
2.1.4 Antares Pharma, Inc. Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Antares Pharma, Inc. Recent Developments/Updates
2.2 UCB
2.2.1 UCB Details
2.2.2 UCB Major Business
2.2.3 UCB Immune Drugs Product and Services
2.2.4 UCB Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 UCB Recent Developments/Updates
2.3 Incyte
2.3.1 Incyte Details
2.3.2 Incyte Major Business
2.3.3 Incyte Immune Drugs Product and Services
2.3.4 Incyte Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Incyte Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Immune Drugs Product and Services
2.4.4 GSK Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Immune Drugs Product and Services
2.5.4 Takeda Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Takeda Recent Developments/Updates
2.6 3S Bio
2.6.1 3S Bio Details
2.6.2 3S Bio Major Business
2.6.3 3S Bio Immune Drugs Product and Services
2.6.4 3S Bio Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 3S Bio Recent Developments/Updates
2.7 Horizo??n Therapeutics
2.7.1 Horizo??n Therapeutics Details
2.7.2 Horizo??n Therapeutics Major Business
2.7.3 Horizo??n Therapeutics Immune Drugs Product and Services
2.7.4 Horizo??n Therapeutics Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Horizo??n Therapeutics Recent Developments/Updates
2.8 Bristol-Myers Squibb (BMS
2.8.1 Bristol-Myers Squibb (BMS Details
2.8.2 Bristol-Myers Squibb (BMS Major Business
2.8.3 Bristol-Myers Squibb (BMS Immune Drugs Product and Services
2.8.4 Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bristol-Myers Squibb (BMS Recent Developments/Updates
2.9 Astellas
2.9.1 Astellas Details
2.9.2 Astellas Major Business
2.9.3 Astellas Immune Drugs Product and Services
2.9.4 Astellas Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Astellas Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Immune Drugs Product and Services
2.10.4 Eli Lilly Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 Mitsubishi Tanabe Pharma
2.11.1 Mitsubishi Tanabe Pharma Details
2.11.2 Mitsubishi Tanabe Pharma Major Business
2.11.3 Mitsubishi Tanabe Pharma Immune Drugs Product and Services
2.11.4 Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Immune Drugs Product and Services
2.12.4 Biogen Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Biogen Recent Developments/Updates
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer Immune Drugs Product and Services
2.13.4 Pfizer Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer Recent Developments/Updates
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Immune Drugs Product and Services
2.14.4 Sanofi Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sanofi Recent Developments/Updates
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Immune Drugs Product and Services
2.15.4 Roche Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Roche Recent Developments/Updates
2.16 Novartis
2.16.1 Novartis Details
2.16.2 Novartis Major Business
2.16.3 Novartis Immune Drugs Product and Services
2.16.4 Novartis Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Novartis Recent Developments/Updates
2.17 Johnson & Johnson (J&J)
2.17.1 Johnson & Johnson (J&J) Details
2.17.2 Johnson & Johnson (J&J) Major Business
2.17.3 Johnson & Johnson (J&J) Immune Drugs Product and Services
2.17.4 Johnson & Johnson (J&J) Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Johnson & Johnson (J&J) Recent Developments/Updates
2.18 Amgen
2.18.1 Amgen Details
2.18.2 Amgen Major Business
2.18.3 Amgen Immune Drugs Product and Services
2.18.4 Amgen Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Amgen Recent Developments/Updates
2.19 Abbvi
2.19.1 Abbvi Details
2.19.2 Abbvi Major Business
2.19.3 Abbvi Immune Drugs Product and Services
2.19.4 Abbvi Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Abbvi Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMMUNE DRUGS BY MANUFACTURER
3.1 Global Immune Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Immune Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Immune Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Immune Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Immune Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Immune Drugs Manufacturer Market Share in 2022
3.5 Immune Drugs Market: Overall Company Footprint Analysis
3.5.1 Immune Drugs Market: Region Footprint
3.5.2 Immune Drugs Market: Company Product Type Footprint
3.5.3 Immune Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Immune Drugs Market Size by Region
4.1.1 Global Immune Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Immune Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Immune Drugs Average Price by Region (2018-2029)
4.2 North America Immune Drugs Consumption Value (2018-2029)
4.3 Europe Immune Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Immune Drugs Consumption Value (2018-2029)
4.5 South America Immune Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Immune Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Immune Drugs Sales Quantity by Type (2018-2029)
5.2 Global Immune Drugs Consumption Value by Type (2018-2029)
5.3 Global Immune Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Immune Drugs Sales Quantity by Application (2018-2029)
6.2 Global Immune Drugs Consumption Value by Application (2018-2029)
6.3 Global Immune Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Immune Drugs Sales Quantity by Type (2018-2029)
7.2 North America Immune Drugs Sales Quantity by Application (2018-2029)
7.3 North America Immune Drugs Market Size by Country
7.3.1 North America Immune Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Immune Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Immune Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Immune Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Immune Drugs Market Size by Country
8.3.1 Europe Immune Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Immune Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Immune Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Immune Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Immune Drugs Market Size by Region
9.3.1 Asia-Pacific Immune Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Immune Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Immune Drugs Sales Quantity by Type (2018-2029)
10.2 South America Immune Drugs Sales Quantity by Application (2018-2029)
10.3 South America Immune Drugs Market Size by Country
10.3.1 South America Immune Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Immune Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Immune Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Immune Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Immune Drugs Market Size by Country
11.3.1 Middle East & Africa Immune Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Immune Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Immune Drugs Market Drivers
12.2 Immune Drugs Market Restraints
12.3 Immune Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Immune Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immune Drugs
13.3 Immune Drugs Production Process
13.4 Immune Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immune Drugs Typical Distributors
14.3 Immune Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Immune Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immune Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Immune Boosting Drugs
1.3.3 Immunosuppressant Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Immune Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Surgery Center
1.4.5 Others
1.5 Global Immune Drugs Market Size & Forecast
1.5.1 Global Immune Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Immune Drugs Sales Quantity (2018-2029)
1.5.3 Global Immune Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Antares Pharma, Inc.
2.1.1 Antares Pharma, Inc. Details
2.1.2 Antares Pharma, Inc. Major Business
2.1.3 Antares Pharma, Inc. Immune Drugs Product and Services
2.1.4 Antares Pharma, Inc. Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Antares Pharma, Inc. Recent Developments/Updates
2.2 UCB
2.2.1 UCB Details
2.2.2 UCB Major Business
2.2.3 UCB Immune Drugs Product and Services
2.2.4 UCB Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 UCB Recent Developments/Updates
2.3 Incyte
2.3.1 Incyte Details
2.3.2 Incyte Major Business
2.3.3 Incyte Immune Drugs Product and Services
2.3.4 Incyte Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Incyte Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK Immune Drugs Product and Services
2.4.4 GSK Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Immune Drugs Product and Services
2.5.4 Takeda Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Takeda Recent Developments/Updates
2.6 3S Bio
2.6.1 3S Bio Details
2.6.2 3S Bio Major Business
2.6.3 3S Bio Immune Drugs Product and Services
2.6.4 3S Bio Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 3S Bio Recent Developments/Updates
2.7 Horizo??n Therapeutics
2.7.1 Horizo??n Therapeutics Details
2.7.2 Horizo??n Therapeutics Major Business
2.7.3 Horizo??n Therapeutics Immune Drugs Product and Services
2.7.4 Horizo??n Therapeutics Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Horizo??n Therapeutics Recent Developments/Updates
2.8 Bristol-Myers Squibb (BMS
2.8.1 Bristol-Myers Squibb (BMS Details
2.8.2 Bristol-Myers Squibb (BMS Major Business
2.8.3 Bristol-Myers Squibb (BMS Immune Drugs Product and Services
2.8.4 Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bristol-Myers Squibb (BMS Recent Developments/Updates
2.9 Astellas
2.9.1 Astellas Details
2.9.2 Astellas Major Business
2.9.3 Astellas Immune Drugs Product and Services
2.9.4 Astellas Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Astellas Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Immune Drugs Product and Services
2.10.4 Eli Lilly Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 Mitsubishi Tanabe Pharma
2.11.1 Mitsubishi Tanabe Pharma Details
2.11.2 Mitsubishi Tanabe Pharma Major Business
2.11.3 Mitsubishi Tanabe Pharma Immune Drugs Product and Services
2.11.4 Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Immune Drugs Product and Services
2.12.4 Biogen Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Biogen Recent Developments/Updates
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer Immune Drugs Product and Services
2.13.4 Pfizer Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pfizer Recent Developments/Updates
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Immune Drugs Product and Services
2.14.4 Sanofi Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sanofi Recent Developments/Updates
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Immune Drugs Product and Services
2.15.4 Roche Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Roche Recent Developments/Updates
2.16 Novartis
2.16.1 Novartis Details
2.16.2 Novartis Major Business
2.16.3 Novartis Immune Drugs Product and Services
2.16.4 Novartis Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Novartis Recent Developments/Updates
2.17 Johnson & Johnson (J&J)
2.17.1 Johnson & Johnson (J&J) Details
2.17.2 Johnson & Johnson (J&J) Major Business
2.17.3 Johnson & Johnson (J&J) Immune Drugs Product and Services
2.17.4 Johnson & Johnson (J&J) Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Johnson & Johnson (J&J) Recent Developments/Updates
2.18 Amgen
2.18.1 Amgen Details
2.18.2 Amgen Major Business
2.18.3 Amgen Immune Drugs Product and Services
2.18.4 Amgen Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Amgen Recent Developments/Updates
2.19 Abbvi
2.19.1 Abbvi Details
2.19.2 Abbvi Major Business
2.19.3 Abbvi Immune Drugs Product and Services
2.19.4 Abbvi Immune Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Abbvi Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMMUNE DRUGS BY MANUFACTURER
3.1 Global Immune Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Immune Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Immune Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Immune Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Immune Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Immune Drugs Manufacturer Market Share in 2022
3.5 Immune Drugs Market: Overall Company Footprint Analysis
3.5.1 Immune Drugs Market: Region Footprint
3.5.2 Immune Drugs Market: Company Product Type Footprint
3.5.3 Immune Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Immune Drugs Market Size by Region
4.1.1 Global Immune Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Immune Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Immune Drugs Average Price by Region (2018-2029)
4.2 North America Immune Drugs Consumption Value (2018-2029)
4.3 Europe Immune Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Immune Drugs Consumption Value (2018-2029)
4.5 South America Immune Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Immune Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Immune Drugs Sales Quantity by Type (2018-2029)
5.2 Global Immune Drugs Consumption Value by Type (2018-2029)
5.3 Global Immune Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Immune Drugs Sales Quantity by Application (2018-2029)
6.2 Global Immune Drugs Consumption Value by Application (2018-2029)
6.3 Global Immune Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Immune Drugs Sales Quantity by Type (2018-2029)
7.2 North America Immune Drugs Sales Quantity by Application (2018-2029)
7.3 North America Immune Drugs Market Size by Country
7.3.1 North America Immune Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Immune Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Immune Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Immune Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Immune Drugs Market Size by Country
8.3.1 Europe Immune Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Immune Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Immune Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Immune Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Immune Drugs Market Size by Region
9.3.1 Asia-Pacific Immune Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Immune Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Immune Drugs Sales Quantity by Type (2018-2029)
10.2 South America Immune Drugs Sales Quantity by Application (2018-2029)
10.3 South America Immune Drugs Market Size by Country
10.3.1 South America Immune Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Immune Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Immune Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Immune Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Immune Drugs Market Size by Country
11.3.1 Middle East & Africa Immune Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Immune Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Immune Drugs Market Drivers
12.2 Immune Drugs Market Restraints
12.3 Immune Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Immune Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immune Drugs
13.3 Immune Drugs Production Process
13.4 Immune Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immune Drugs Typical Distributors
14.3 Immune Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Immune Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immune Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Antares Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Antares Pharma, Inc. Major Business
Table 5. Antares Pharma, Inc. Immune Drugs Product and Services
Table 6. Antares Pharma, Inc. Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Antares Pharma, Inc. Recent Developments/Updates
Table 8. UCB Basic Information, Manufacturing Base and Competitors
Table 9. UCB Major Business
Table 10. UCB Immune Drugs Product and Services
Table 11. UCB Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. UCB Recent Developments/Updates
Table 13. Incyte Basic Information, Manufacturing Base and Competitors
Table 14. Incyte Major Business
Table 15. Incyte Immune Drugs Product and Services
Table 16. Incyte Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Incyte Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Immune Drugs Product and Services
Table 21. GSK Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Takeda Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Major Business
Table 25. Takeda Immune Drugs Product and Services
Table 26. Takeda Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Takeda Recent Developments/Updates
Table 28. 3S Bio Basic Information, Manufacturing Base and Competitors
Table 29. 3S Bio Major Business
Table 30. 3S Bio Immune Drugs Product and Services
Table 31. 3S Bio Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. 3S Bio Recent Developments/Updates
Table 33. Horizo??n Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Horizo??n Therapeutics Major Business
Table 35. Horizo??n Therapeutics Immune Drugs Product and Services
Table 36. Horizo??n Therapeutics Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Horizo??n Therapeutics Recent Developments/Updates
Table 38. Bristol-Myers Squibb (BMS Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb (BMS Major Business
Table 40. Bristol-Myers Squibb (BMS Immune Drugs Product and Services
Table 41. Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bristol-Myers Squibb (BMS Recent Developments/Updates
Table 43. Astellas Basic Information, Manufacturing Base and Competitors
Table 44. Astellas Major Business
Table 45. Astellas Immune Drugs Product and Services
Table 46. Astellas Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Astellas Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Immune Drugs Product and Services
Table 51. Eli Lilly Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Mitsubishi Tanabe Pharma Major Business
Table 55. Mitsubishi Tanabe Pharma Immune Drugs Product and Services
Table 56. Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 58. Biogen Basic Information, Manufacturing Base and Competitors
Table 59. Biogen Major Business
Table 60. Biogen Immune Drugs Product and Services
Table 61. Biogen Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Biogen Recent Developments/Updates
Table 63. Pfizer Basic Information, Manufacturing Base and Competitors
Table 64. Pfizer Major Business
Table 65. Pfizer Immune Drugs Product and Services
Table 66. Pfizer Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Pfizer Recent Developments/Updates
Table 68. Sanofi Basic Information, Manufacturing Base and Competitors
Table 69. Sanofi Major Business
Table 70. Sanofi Immune Drugs Product and Services
Table 71. Sanofi Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sanofi Recent Developments/Updates
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Immune Drugs Product and Services
Table 76. Roche Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Roche Recent Developments/Updates
Table 78. Novartis Basic Information, Manufacturing Base and Competitors
Table 79. Novartis Major Business
Table 80. Novartis Immune Drugs Product and Services
Table 81. Novartis Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Novartis Recent Developments/Updates
Table 83. Johnson & Johnson (J&J) Basic Information, Manufacturing Base and Competitors
Table 84. Johnson & Johnson (J&J) Major Business
Table 85. Johnson & Johnson (J&J) Immune Drugs Product and Services
Table 86. Johnson & Johnson (J&J) Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Johnson & Johnson (J&J) Recent Developments/Updates
Table 88. Amgen Basic Information, Manufacturing Base and Competitors
Table 89. Amgen Major Business
Table 90. Amgen Immune Drugs Product and Services
Table 91. Amgen Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Amgen Recent Developments/Updates
Table 93. Abbvi Basic Information, Manufacturing Base and Competitors
Table 94. Abbvi Major Business
Table 95. Abbvi Immune Drugs Product and Services
Table 96. Abbvi Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Abbvi Recent Developments/Updates
Table 98. Global Immune Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Immune Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Immune Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in Immune Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Immune Drugs Production Site of Key Manufacturer
Table 103. Immune Drugs Market: Company Product Type Footprint
Table 104. Immune Drugs Market: Company Product Application Footprint
Table 105. Immune Drugs New Market Entrants and Barriers to Market Entry
Table 106. Immune Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Immune Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global Immune Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Immune Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Immune Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Immune Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global Immune Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Immune Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Immune Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Immune Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Immune Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Immune Drugs Raw Material
Table 166. Key Manufacturers of Immune Drugs Raw Materials
Table 167. Immune Drugs Typical Distributors
Table 168. Immune Drugs Typical Customers
Table 1. Global Immune Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Immune Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Antares Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Antares Pharma, Inc. Major Business
Table 5. Antares Pharma, Inc. Immune Drugs Product and Services
Table 6. Antares Pharma, Inc. Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Antares Pharma, Inc. Recent Developments/Updates
Table 8. UCB Basic Information, Manufacturing Base and Competitors
Table 9. UCB Major Business
Table 10. UCB Immune Drugs Product and Services
Table 11. UCB Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. UCB Recent Developments/Updates
Table 13. Incyte Basic Information, Manufacturing Base and Competitors
Table 14. Incyte Major Business
Table 15. Incyte Immune Drugs Product and Services
Table 16. Incyte Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Incyte Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK Immune Drugs Product and Services
Table 21. GSK Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Takeda Basic Information, Manufacturing Base and Competitors
Table 24. Takeda Major Business
Table 25. Takeda Immune Drugs Product and Services
Table 26. Takeda Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Takeda Recent Developments/Updates
Table 28. 3S Bio Basic Information, Manufacturing Base and Competitors
Table 29. 3S Bio Major Business
Table 30. 3S Bio Immune Drugs Product and Services
Table 31. 3S Bio Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. 3S Bio Recent Developments/Updates
Table 33. Horizo??n Therapeutics Basic Information, Manufacturing Base and Competitors
Table 34. Horizo??n Therapeutics Major Business
Table 35. Horizo??n Therapeutics Immune Drugs Product and Services
Table 36. Horizo??n Therapeutics Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Horizo??n Therapeutics Recent Developments/Updates
Table 38. Bristol-Myers Squibb (BMS Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb (BMS Major Business
Table 40. Bristol-Myers Squibb (BMS Immune Drugs Product and Services
Table 41. Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bristol-Myers Squibb (BMS Recent Developments/Updates
Table 43. Astellas Basic Information, Manufacturing Base and Competitors
Table 44. Astellas Major Business
Table 45. Astellas Immune Drugs Product and Services
Table 46. Astellas Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Astellas Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Immune Drugs Product and Services
Table 51. Eli Lilly Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Mitsubishi Tanabe Pharma Major Business
Table 55. Mitsubishi Tanabe Pharma Immune Drugs Product and Services
Table 56. Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 58. Biogen Basic Information, Manufacturing Base and Competitors
Table 59. Biogen Major Business
Table 60. Biogen Immune Drugs Product and Services
Table 61. Biogen Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Biogen Recent Developments/Updates
Table 63. Pfizer Basic Information, Manufacturing Base and Competitors
Table 64. Pfizer Major Business
Table 65. Pfizer Immune Drugs Product and Services
Table 66. Pfizer Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Pfizer Recent Developments/Updates
Table 68. Sanofi Basic Information, Manufacturing Base and Competitors
Table 69. Sanofi Major Business
Table 70. Sanofi Immune Drugs Product and Services
Table 71. Sanofi Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Sanofi Recent Developments/Updates
Table 73. Roche Basic Information, Manufacturing Base and Competitors
Table 74. Roche Major Business
Table 75. Roche Immune Drugs Product and Services
Table 76. Roche Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Roche Recent Developments/Updates
Table 78. Novartis Basic Information, Manufacturing Base and Competitors
Table 79. Novartis Major Business
Table 80. Novartis Immune Drugs Product and Services
Table 81. Novartis Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Novartis Recent Developments/Updates
Table 83. Johnson & Johnson (J&J) Basic Information, Manufacturing Base and Competitors
Table 84. Johnson & Johnson (J&J) Major Business
Table 85. Johnson & Johnson (J&J) Immune Drugs Product and Services
Table 86. Johnson & Johnson (J&J) Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Johnson & Johnson (J&J) Recent Developments/Updates
Table 88. Amgen Basic Information, Manufacturing Base and Competitors
Table 89. Amgen Major Business
Table 90. Amgen Immune Drugs Product and Services
Table 91. Amgen Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Amgen Recent Developments/Updates
Table 93. Abbvi Basic Information, Manufacturing Base and Competitors
Table 94. Abbvi Major Business
Table 95. Abbvi Immune Drugs Product and Services
Table 96. Abbvi Immune Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Abbvi Recent Developments/Updates
Table 98. Global Immune Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Immune Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Immune Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in Immune Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Immune Drugs Production Site of Key Manufacturer
Table 103. Immune Drugs Market: Company Product Type Footprint
Table 104. Immune Drugs Market: Company Product Application Footprint
Table 105. Immune Drugs New Market Entrants and Barriers to Market Entry
Table 106. Immune Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Immune Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global Immune Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Immune Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Immune Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Immune Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global Immune Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Immune Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Immune Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Immune Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Immune Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Immune Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Immune Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Immune Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Immune Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Immune Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Immune Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Immune Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Immune Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Immune Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Immune Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Immune Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Immune Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Immune Drugs Raw Material
Table 166. Key Manufacturers of Immune Drugs Raw Materials
Table 167. Immune Drugs Typical Distributors
Table 168. Immune Drugs Typical Customers
LIST OF FIGURES
Figure 1. Immune Drugs Picture
Figure 2. Global Immune Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immune Drugs Consumption Value Market Share by Type in 2022
Figure 4. Immune Boosting Drugs Examples
Figure 5. Immunosuppressant Drugs Examples
Figure 6. Global Immune Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Immune Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Surgery Center Examples
Figure 11. Others Examples
Figure 12. Global Immune Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Immune Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Immune Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Immune Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Immune Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Immune Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Immune Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Immune Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Immune Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Immune Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Immune Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Immune Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Immune Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Immune Drugs Market Drivers
Figure 75. Immune Drugs Market Restraints
Figure 76. Immune Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Immune Drugs in 2022
Figure 79. Manufacturing Process Analysis of Immune Drugs
Figure 80. Immune Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Immune Drugs Picture
Figure 2. Global Immune Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Immune Drugs Consumption Value Market Share by Type in 2022
Figure 4. Immune Boosting Drugs Examples
Figure 5. Immunosuppressant Drugs Examples
Figure 6. Global Immune Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Immune Drugs Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Surgery Center Examples
Figure 11. Others Examples
Figure 12. Global Immune Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Immune Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Immune Drugs Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Immune Drugs Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Immune Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Immune Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Immune Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Immune Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Immune Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Immune Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Immune Drugs Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Immune Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Immune Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Immune Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 54. China Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Immune Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Immune Drugs Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Immune Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Immune Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Immune Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Immune Drugs Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Immune Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Immune Drugs Market Drivers
Figure 75. Immune Drugs Market Restraints
Figure 76. Immune Drugs Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Immune Drugs in 2022
Figure 79. Manufacturing Process Analysis of Immune Drugs
Figure 80. Immune Drugs Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
